|
Some breast
cancer patients who undergo a lumpectomy should then be considered
for an magnetic resonance examination because MR is an accurate
way to look for any disease left in the breast, according to Memorial
Sloan Kettering Cancer Center researchers.
Reporting
at the American Roentgen Ray Socilety annual meeting, Dr. Elizabeth
Morris said that in one study, radiologists reviewed tumor speciments
from 100 patients who had undergone a lumpectomy and found that
the cancer had spread to or near the edge (margins) of the specimen.
When these
100 women then had an MR examination, radiologists found that
58 had disease left over after lumpectomy.
Overall, MR
imaging identified 86 percent of residual disease, Morris said.
she says.
A separate
study of women with ductal carcinoma in situ produced similar
results.
In the study,
"MR imaging identified residual disease near the lumpectomy
site in 18 of the 23 breasts," reported Dr. Jennifer Menell.
Nine of these
women also had a mammogram, and MR identified residual disease
in seven of these nine patients while mammography identified residual
disease in only six.
"MR imaging
provides us with a window to the breast that we haven't had before
and maps out for us how extensive the disease really is,"
said Dr. Morris. "If tumor extent can be accurately gauged,
appropriate treatment can be planned."
Other
sources: American Roentgen Ray Society
|